THURSDAY, Sept. 12, 2024 -- The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the...
Vous n'êtes pas connecté
Obesity medication Zepbound will be available to buy in 2.5-milligram and 5-milligram single-dose vials on manufacturer Eli Lilly's telehealth platform, the company has announced.
THURSDAY, Sept. 12, 2024 -- The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the...
All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but...
Weight loss jabs could be prescribed to children as young as six after trials found they slashed obesity and tackled other health issues.
Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.
Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.
TERN stock soars on positive data from the early-stage study of TERN-601 for obesity, showing statistically significant weight reduction compared to...
LEHI, Utah., Sept. 12, 2024. Biolexis Therapeutics, a biopharmaceutical company pioneering next-generation weight loss treatments, today announced the...
Investors seeking to tap the boom in weight-loss drug treatment could consider these ETFs.
Investors can buy LLY stock based on its strong overall financial performance and robust drug pipeline.